Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:16 pm Purchase | 2024-02-09 | 13D | PEPGEN INC PEPG | RA CAPITAL MANAGEMENT L.P. | 10,695,135 34.100% | 2,563,183 (+31.52%) | Filing History |
| 2024-02-12 4:49 pm Purchase | 2024-02-12 | 13D | MINERALYS THERAPEUTICS INC MLYS | RA CAPITAL MANAGEMENT L.P. | 4,949,307 9.990% | 1,768,387 (+55.59%) | Filing History |
| 2024-02-12 4:18 pm Purchase | 2024-02-02 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | RA CAPITAL MANAGEMENT L.P. | 430,182 4.100% | 430,182 (New Position) | Filing History |
| 2024-02-12 4:17 pm Purchase | 2024-02-01 | 13G | ASTRIA THERAPEUTICS INC ATXS | RA CAPITAL MANAGEMENT L.P. | 4,413,150 8.100% | 4,413,150 (New Position) | Filing History |
| 2024-02-06 4:40 pm Purchase | 2024-02-06 | 13D | TYRA BIOSCIENCES INC TYRA | RA CAPITAL MANAGEMENT L.P. | 10,475,489 19.990% | 3,239,035 (+44.76%) | Filing History |
| 2024-02-05 4:30 pm Purchase | 2024-01-25 | 13G | ADICET BIO INC ACET | RA CAPITAL MANAGEMENT L.P. | 481,059 9.990% | 481,059 (New Position) | Filing History |
| 2024-02-01 6:22 pm Purchase | 2024-01-22 | 13G | DIANTHUS THERAPEUTICS INC DNTH | RA CAPITAL MANAGEMENT L.P. | 2,995,023 9.990% | 2,995,023 (New Position) | Filing History |
| 2024-01-29 4:30 pm Purchase | 2024-01-19 | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 8,909,091 9.600% | 8,909,091 (New Position) | Filing History |
| 2024-01-19 4:30 pm Purchase | 2024-01-18 | 13G | VAXART INC VXRT | RA CAPITAL MANAGEMENT L.P. | 15,384,615 9.100% | 15,384,615 (New Position) | Filing History |
| 2024-01-12 5:00 pm Purchase | 2024-01-02 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | RA CAPITAL MANAGEMENT L.P. | 3,073,119 8.700% | 3,073,119 (New Position) | Filing History |
| 2024-01-11 5:24 pm Purchase | 2024-01-11 | 13D | SOLID BIOSCIENCES INC SLDB | RA CAPITAL MANAGEMENT L.P. | 4,348,828 11.700% | 917,210 (+26.73%) | Filing History |
| 2023-12-29 4:30 pm Purchase | 2023-12-19 | 13G | UROGEN PHARMA LTD URGN | RA CAPITAL MANAGEMENT L.P. | 3,083,550 9.990% | 3,083,550 (New Position) | Filing History |
| 2023-12-26 4:30 pm Purchase | 2023-12-14 | 13G | C4 THERAPEUTICS INC CCCC | RA CAPITAL MANAGEMENT L.P. | 4,878,000 9.900% | 4,878,000 (New Position) | Filing History |
| 2023-12-20 4:30 pm Sale | 2023-12-18 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA CAPITAL MANAGEMENT L.P. | 3,062,871 5.600% | -2,061,438 (-40.23%) | Filing History |
| 2023-12-14 4:30 pm Sale | 2023-12-12 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA CAPITAL MANAGEMENT L.P. | 5,124,309 9.300% | -830,702 (-13.95%) | Filing History |
| 2023-12-13 4:30 pm Purchase | 2023-12-11 | 13D | 89BIO INC ETNB | RA CAPITAL MANAGEMENT L.P. | 12,875,855 13.600% | 1,041 (+0.01%) | Filing History |
| 2023-12-04 5:20 pm Sale | 2023-11-30 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA CAPITAL MANAGEMENT L.P. | 5,955,011 10.800% | -1,035,992 (-14.82%) | Filing History |
| 2023-11-27 4:30 pm Purchase | 2023-11-16 | 13G | THIRD HARMONIC BIO INC THRD | RA CAPITAL MANAGEMENT L.P. | 2,033,056 5.000% | 1,498,369 (+280.23%) | Filing History |
| 2023-11-17 4:30 pm Purchase | 2023-11-15 | 13D | CLIMB BIO, INC. CLYM | RA CAPITAL MANAGEMENT L.P. | 13,176,403 47.700% | 13,332 (+0.10%) | Filing History |
| 2023-11-14 5:00 pm Sale | 2023-11-14 | 13G | DESIGN THERAPEUTICS INC DSGN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -2,971,231 (Position Closed) | Filing History |